These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6555016)

  • 1. Synergy of combinations of vancomycin, gentamicin, and rifampin against methicillin-resistant, coagulase-negative staphylococci.
    Lowy FD; Chang DS; Lash PR
    Antimicrob Agents Chemother; 1983 Jun; 23(6):932-4. PubMed ID: 6555016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between rifampin and fusidic acid against methicillin-resistant coagulase-positive and -negative staphylococci.
    Farber BF; Yee YC; Karchmer AW
    Antimicrob Agents Chemother; 1986 Jul; 30(1):174-5. PubMed ID: 3638931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergy study of vancomycin or teicoplanin plus gentamicin against enterococci, Staphylococcus aureus and coagulase-negative staphylococci by time-kill method.
    Thamlikitkul V
    J Med Assoc Thai; 1991 Dec; 74(12):669-74. PubMed ID: 1839906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergism between vancomycin and gentamicin or tobramycin for methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains.
    Watanakunakorn C; Tisone JC
    Antimicrob Agents Chemother; 1982 Nov; 22(5):903-5. PubMed ID: 6924825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro effects of vancomycin and rifampicin, alone and in combination, against methicillin-sensitive and methicillin-resistant staphylococci.
    Varaldo PE; Debbia E; Schito GC
    J Antimicrob Chemother; 1984 Dec; 14 Suppl D():35-41. PubMed ID: 6569872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparity between timed-kill and checkerboard methods for determination of in vitro bactericidal interactions of vancomycin plus rifampin versus methicillin-susceptible and -resistant Staphylococcus aureus.
    Bayer AS; Morrison JO
    Antimicrob Agents Chemother; 1984 Aug; 26(2):220-3. PubMed ID: 6567464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility and synergy studies of methicillin-resistant Staphylococcus epidermidis.
    Ein ME; Smith NJ; Aruffo JF; Heerema MS; Bradshaw MW; Williams TW
    Antimicrob Agents Chemother; 1979 Nov; 16(5):655-9. PubMed ID: 260880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percentages and distributions of teicoplanin- and vancomycin-resistant strains among coagulase-negative staphylococci.
    Goldstein FW; Coutrot A; Sieffer A; Acar JF
    Antimicrob Agents Chemother; 1990 May; 34(5):899-900. PubMed ID: 2141780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective treatment of cephalosporin-rifampin combinations against cryptic methicillin-resistant beta-lactamase-producing coagulase-negative staphylococcal experimental endocarditis.
    Brandt CM; Rouse MS; Tallan BM; Laue NW; Wilson WR; Steckelberg JM
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1815-9. PubMed ID: 7486924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New trends in the chemotherapy of staphylococcal infections.
    Russo G; Tempera G; Stefani S; Nicoletti G
    Chemioterapia; 1986 Apr; 5(2):116-9. PubMed ID: 3635440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vancomycin-gentamicin synergism revisited: effect of gentamicin susceptibility of methicillin-resistant Staphylococcus aureus.
    Mulazimoglu L; Drenning SD; Muder RR
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1534-5. PubMed ID: 8726033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin and oxacillin synergy for methicillin-resistant staphylococci.
    Domaracki BE; Evans AM; Venezia RA
    Antimicrob Agents Chemother; 2000 May; 44(5):1394-6. PubMed ID: 10770789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newer agents against methicillin and/or gentamicin-resistant and -susceptible staphylococci.
    Chandrasekar PH; Sluchak JA
    Chemotherapy; 1989; 35(5):333-7. PubMed ID: 2551600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activities of rifapentine and rifampin, alone and in combination with six other antibiotics, against methicillin-susceptible and methicillin-resistant staphylococci of different species.
    Varaldo PE; Debbia E; Schito GC
    Antimicrob Agents Chemother; 1985 Apr; 27(4):615-8. PubMed ID: 3847272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novobiocin and rifampicin in combination against methicillin-resistant Staphylococcus aureus: an in-vitro comparison with vancomycin plus rifampicin.
    Walsh TJ; Auger F; Tatem BA; Hansen SL; Standiford HC
    J Antimicrob Chemother; 1986 Jan; 17(1):75-82. PubMed ID: 3633267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sensitivity of methicillin-resistant Staphylococcus aureus to vancomycin, gentamicin and pristinamycin].
    Yourassowsky E; Schoutens E
    Acta Clin Belg; 1971; 26(3):139-45. PubMed ID: 5211728
    [No Abstract]   [Full Text] [Related]  

  • 17. In-vitro effects of vancomycin, rifampicin, and fusidic acid, alone and in combination, against methicillin-resistant Staphylococcus aureus.
    Foldes M; Munro R; Sorrell TC; Shanker S; Toohey M
    J Antimicrob Chemother; 1983 Jan; 11(1):21-6. PubMed ID: 6826485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effect of quinolones and oxacillin on methicillin-resistant Staphylococcus species.
    Rohner P; Herter C; Auckenthaler R; Pechère JC; Waldvogel FA; Lew DP
    Antimicrob Agents Chemother; 1989 Dec; 33(12):2037-41. PubMed ID: 2619272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus.
    Grohs P; Kitzis MD; Gutmann L
    Antimicrob Agents Chemother; 2003 Jan; 47(1):418-20. PubMed ID: 12499229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro activity of teicoplanin alone and in combination with rifampicin, gentamicin or tobramycin against coagulase-negative staphylococci.
    Watanakunakorn C
    J Antimicrob Chemother; 1987 Apr; 19(4):439-43. PubMed ID: 2953706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.